-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AFiOxTr04K4E1wZxRNIRM3Q9UylE5BNM8EYgaa6Qxlx5or4ewCoDo6DdRTlLCkV5 ue7gfAGA01wEDxx9ssCCpw== 0000950116-02-000191.txt : 20020414 0000950116-02-000191.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950116-02-000191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020131 FILED AS OF DATE: 20020208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 02531770 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANA STATE: A1 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO M5J STATE: A1 COMPANY DATA: COMPANY CONFORMED NAME: GLUSKIN ANNA E CENTRAL INDEX KEY: 0001125857 OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQUARE STE 202 CITY: TORONTO STATE: A6 ZIP: M5H2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: C/O GENEREX BIOTECHNOLOGY CORP STREET 2: 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CITY: CANADA M5J2G2 4 1 four.txt 4 FORM 4 [ ] Check box if no ------------------------------------ longer subject to OMB APPROVAL Section 16. Form 4 or ------------------------------------ Form 5 obligations may OMB Number 3235-0287 continue. See Instruction 1(b) Expires: December 31, 2001 Estimated average burden hours per response .............0.5 ------------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - ------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Gluskin Anna E. -------------------------------------------------------------------- (Last) (First) (Middle) 33 Harbour Square, Suite 202 -------------------------------------------------------------------- (Street) Toronto, Ontario (Canada) M5J 2G2 -------------------------------------------------------------------- (City) (State) (Zip) - ------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Generex Biotechnology Corporation (GNBT) - ------------------------------------------------------------------------------- 3. IRS or Social Security Number of Reporting Person (Voluntary) - ------------------------------------------------------------------------------- 4. Statement for Month/Year | 5. If Amendment, Date of | Original (Month/Year) January/2002 | - ------------------------------------------------------------------------------- 6. Relationship of Reporting Person to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ X ] Officer [ ] Other (specify below) (give title below) President and Chief Executive Officer - ------------------------------------------------------------------------------- 7. Individual or Joint/Group Reporting (Check Applicable Line) X Form Filed by One Reporting Person --- Form Filed by More than One Reporting Person --- - ------------------------------------------------------------------------------- - ------------------------------------------------------------------------------- TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - -------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 2. Transaction Date | 3. Transaction Code | 4. Security Acquired (A) or Disposed (Instr. 3) | (Month/Day/Year) | (Instr. 8) | of (D) (Instr. 3, 4 and 5) | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | Amount | (A) or| Price | | | | (D) | - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/22/02 | P | 1,000 | (A) | $6.39 - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/22/02 | P | 1,000 | (A) | $6.50 - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1/25/02 | P | 1,000 | (A) | $6.54 - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
- --------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 5. Amount of Securities | 6. Ownership Form: | 7. Nature of Indirect Beneficial (Instr. 3) | Beneficially Owned at | Direct (D) or | Ownership (Instr. 4) | End of Month | Indirect (I) | | (Instr. 3 & 4) | (Instr. 4) | - --------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | - --------------------------------------------------------------------------------------------------------------------------------- Common Stock | | | - --------------------------------------------------------------------------------------------------------------------------------- Common Stock | 3,000 | D | - --------------------------------------------------------------------------------------------------------------------------------- Common Stock | 1,188,127 | I | by GHI, Inc. - --------------------------------------------------------------------------------------------------------------------------------- | | | =================================================================================================================================
*If the form is filed by more than one reporting person, see Instruction 4(b)(v). (over) SEC 1474 (3-91) FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 2. Conversion or | 3. Transaction Date | 4. Transaction | 5. Number of Derivative (Instr. 3) | Exercise Price of | (Month/Day/Year) | Code | Securities Acquired | Derivative Security | | (Instr. 8) | (A) or Disposed of | | | | (D) (Instr. 3, 4 and 5) - ----------------------------------------------------------------------------------------------------------------------------------- | (A) | (D) - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | $5.00 | | | | - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | $7.5625 | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 6. Date Exercisable and | 7. Title and Amount of Underlying | 8. Price of Derivative (Instr. 3) | Expiration Date | Securities (Instr. 3 and 4) | Security (Instr. 5) | (Month/Day/Year) | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | Date | Expiration | Title | Amount or Number | | Exercisable | Date | | of Shares | | | | | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 1/3/00 | 1/3/05 | Common Stock | 100,000 | - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 7/31/00 | 7/31/05 | Common Stock | 200,000 | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 9. Number Derivative | 10. Ownership of Derivative | 11. Nature of Indirect (Instr. 3) | Securities Beneficially | Security: Direct (D) or | Beneficial Ownership | Owned at End of Month | Indirect (I) (Instr. 4) | (Instr. 4) | (Instr. 4) | | - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | | | - ----------------------------------------------------------------------------------------------------------------------------------- Option to buy | 300,000 | D | - ----------------------------------------------------------------------------------------------------------------------------------- | | | ===================================================================================================================================
Explanation of Responses: /s/ Anna E. Gluskin February 8, 2002 - ------------------------------------ ------------------- **Signature of Reporting Person Date Anna E. Gluskin ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). -----END PRIVACY-ENHANCED MESSAGE-----